Japanese Society for Dialysis Therapy Guidelines for Management of Cardiovascular Diseases in Patients on Chronic Hemodialysis
Open Access
- 10 October 2012
- journal article
- review article
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 16 (5) , 387-435
Abstract
No abstract availableThis publication has 260 references indexed in Scilit:
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialThe Lancet, 2011
- Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patientsKidney International, 2007
- Home blood pressure monitoring improves the diagnosis of hypertension in hemodialysis patientsKidney International, 2006
- Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysisClinical and Experimental Nephrology, 2004
- Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathyJACC, 2003
- Atherosclerotic cardiovascular disease risks in chronic hemodialysis patientsKidney International, 2000
- Long-term outcome of dialysis patients in the United States with coronary revascularization proceduresKidney International, 1999
- Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal diseaseKidney International, 1996
- Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factorsKidney International, 1995
- Prolongation of the QT interval induced by probucol: Demonstration of a method for determining QT interval change induced by a drugAmerican Heart Journal, 1984